Page 3 - Lon Gsk News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lon gsk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lon Gsk Today - Breaking & Trending Today
GSK plc (LON:GSK – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,411.86 ($17.83) and traded as high as GBX 1,439 ($18.18). GSK shares last traded at GBX 1,434.40 ($18.12), with a volume of 2,864,527 shares traded. Wall Street Analysts […] ....
GSK plc (LON:GSK – Get Free Report) announced a dividend on Wednesday, November 1st, Upcoming.Co.Uk reports. Shareholders of record on Thursday, November 16th will be paid a dividend of GBX 14 ($0.17) per share on Thursday, January 11th. This represents a yield of 0.96%. The ex-dividend date is Thursday, November 16th. The official announcement can […] ....
GSK (LON:GSK – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Deutsche Bank Aktiengesellschaft in a research note issued on Tuesday, Digital Look reports. Other equities research analysts have also issued reports about the stock. Morgan Stanley upped their price target on shares of GSK from GBX 1,440 ($17.41) to […] ....
GSK plc (LON:GSK – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eight research firms that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and three have issued a buy recommendation on the company. […] ....
JPMorgan Chase & Co. restated their underweight rating on shares of GSK (LON:GSK – Free Report) in a research note published on Friday morning, MarketBeat.com reports. Several other analysts have also recently issued reports on the stock. Deutsche Bank Aktiengesellschaft restated a buy rating and set a GBX 1,700 ($20.76) target price on shares of […] ....